Back to UBS Group AG UBS Group AG

KYKYNB
5 quarters

Position history for UBS Group AGUBS Group AG's holdings in KYNTRA BIO INC

UBS Group AG holds 7,857 shares of KYNB (KYNTRA BIO INC), worth $59,320 as of 2026-Q2. The position was decreased (-71.5% shares).

Current Value

$59,320

Current Shares

7,857

Total Value Change

+$4,799

Total Shares Change

-2,430

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
7,857
-71.5%
$59,3200.0%$7.55
0
2026-Q1
Increased
27,591
+192.5%
$187,0670.0%$6.84
25
2025-Q4
Increased
9,432
+8.8%
$82,8130.0%$8.70
16
2025-Q3
Decreased
8,667
-15.8%
$106,1710.0%$12.31
0
2025-Q2
New
10,287
-
$54,5210.0%$5.22
32

Other major holders of KYNB: VANGUARD GROUP INC, VANGUARD CAPITAL MANAGEMENT LLC, BlackRock, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used